Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease: PRAETORIAN-COVID (NCT04335786)

DHF Gommans, J Nas, SJ Pinto-Sietsma, Y Koop, RE Konst, F Mensink, GWA Aarts, LSF Konijnenberg, K Cortenbach, DVM Verhaert, J Thannhauser, JQ Mol, MJP Rooijakkers, JL Vos, A van Rumund, P Vart, RJ Hassing, JH Cornel, CP Jager, MM HeuvelHG van der Hoeven, Annelies Verbon, YM Pinto, N Royen, RRL van Kimmenade, PW de Leeuw, MA Van Agtmael, P Bresser, WH van Gilst, A Vonk-Noordergraaf, JGP Tijssen

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)60-68
Number of pages9
JournalAmerican Heart Journal
Publication statusPublished - 2020

Research programs

  • EMC MM-04-28-01
  • EMC OR-01

Cite this